Alternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others), By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others), By End Users (Hospitals and Clinics, Cancer and Radia
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationAlternative Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented By Therapy Type (Hormone Therapies, Acupuncture and Dietary Supplements, Others), By Disease Type (Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others), By End Users (Hospitals and Clinics, Cancer and Radia
Global Alternative Cancer Therapeutics market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising number of aging population, which is susceptible to different types of cancers. Additionally, the growing number of market players along with growing awareness of new therapies among aging population is a major factor which will further drive the growth of the market during the forecast period. Also, rapidly growing adoption of new therapies such as acupuncture, aromatherapy, yoga and other alternative therapies for pain management will further drive the growth of the market in the forecast period. Also, growing insurance coverage for the alternative cancer treatment along with growing initiatives by government organizations to educate people about new therapy will drive the growth of the market over the years.
Growing Prevalence of Cancer
In 2022 the National Cancer Institute, estimated around 26,380 new stomach cancer cases and 11,090 deaths in the United States.
Rising Healthcare Expenditure
(NIH) invested USD460 million in breast cancer which increased to USD3.5 billion in the year 2022.
Market Segmentation
Global alternative cancer therapeutics market can be segmented based on therapy type, disease type, end users, region and competitive landscape. Based on the therapy type, the market can be segmented into Hormone Therapies, Acupuncture and Dietary Supplements, Others. Based on Diseases Type, the market can be segmented into Gastrointestinal, Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Melanoma, Prostate Cancer, Others. Based on the End Users, the market can be differentiated into Hospitals and Clinics, cancer and Radiation Therapy Center, Home Care, Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global alternative cancer therapeutics market on account of the increasing incidence of different types of cancer in the country.
Recent Development
In February 2018, Health Canada approved Janssens Zytiga in combination with prednisone and androgen deprivation therapy for the treatment of patients with newly diagnosed, high risk metastatic hormone sensitive prostate cancer who have received up to three months of prior androgen deprivation therapy.
In April 2020, the US FDA supported Trodelvy (sacituzumab govitecan-hziy) for the therapy of adult patients with triple-negative breast cancer. Trodelvy is a Trop-2-coordinated immunizer and topoisomerase inhibitor drug form, which focuses on the Trop-2 receptor that helps cancer develop, separate, and spread.
Market Players
Innovative Medicine, LLC. ,Northwest Natural Health Clinic, Immunotherapy Institute, Georgia Cancer Specialists, Holistic Bio Spa, Johnson & Johnson, Celgene Corporation, Astellas Pharma,Inc., Novartis AG, Merck KGaA are some of the leading players operating in the Global
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | · By Therapy Type · By Disease Type · By End Users · By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
| Key companies profiled | Innovative Medicine, LLC ,Northwest Natural Health Clinic, Immunotherapy Institute, Georgia Cancer Specialists, Holistic Bio Spa, Johnson & Johnson, Celgene Corporation, Astellas Pharma,Inc., Novartis AG., Merck KGaA. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy